Detailed price information for Bridgebio Oncology Therapeutics Inc (BBOT-Q) from The Globe and Mail including charting and trades.
Beta-Barium Borate (BBO) is a nonlinear crystal characterised by a broad phase-matchable range from 409.6nm to 3500nm, a wide transmission region from 190nm to 3500nm and a high laser damage threshold ...
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway ...
EKSMA Optics offers β-BBO crystals to enable your photonics innovations. Wide transparency ranges between 190 nm to 3500 nm and phase matching conditions covering the range from 200 nm to 2600 nm, are ...
Researchers from Bridgebio Pharma Inc. recently presented BBO-10203, a first-in-class, orally bioavailable, covalent small-molecule candidate designed to inhibit RAS-driven PI3Kα activity without ...
Mutations in the gene encoding PI3Kα are associated with several types of cancer, but selectively targeting oncogenic signalling while leaving physiological PI3Kα activity intact has proved ...
Detailed price information for Bridgebio Oncology Therapeutics Inc (BBOT-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback